newsTwenty-seven Alzheimer's drugs in Phase III clinical trials and eight…
19 July 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Twenty-seven Alzheimer's drugs in Phase III clinical trials and eight drugs in Phase II clinical trials may launch in the next five years...